Panhypopituitarism
Symptoms, Doctors, Treatments, Advances & More

Learn About Panhypopituitarism

What is the definition of Panhypopituitarism?

Combined pituitary hormone deficiency is a condition that causes a partial or complete loss (deficiency) of two or more hormones that are normally produced by the pituitary gland. The pituitary gland, which is located at the base of the brain, produces hormones that are needed for growth, development, and other critical body functions. A lack of pituitary hormones can affect growth and development.

What are the causes of Panhypopituitarism?

Variants (also called mutations) in several genes that play important roles in early development have been associated with congenital combined pituitary hormone deficiency. PROP1 gene variants are the most common genetic cause of congenital combined pituitary hormone deficiency and are more common in individuals with ancestors from Eastern Europe or the Iberian Peninsula. Variants in other genes have been identified in a smaller number of affected individuals.

How prevalent is Panhypopituitarism?

The congenital form of combined pituitary hormone deficiency occurs in approximately 1 in 16,000 individuals.

Is Panhypopituitarism an inherited disorder?

Congenital combined pituitary hormone deficiency can be inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Some cases of this condition are caused by new (de novo) variants in the gene that occur during the formation of reproductive cells (eggs or sperm) in an affected individual's parent or during early embryonic development. These affected individuals typically have no history of the disorder in their family.

Who are the top Panhypopituitarism Local Doctors?
Ilan Gabriely
Advanced in Panhypopituitarism
Endocrinology | Internal Medicine
Advanced in Panhypopituitarism
Endocrinology | Internal Medicine

Reading Hospital Endocrinology & Diabetes Center Wyomissing

1001 Reed Ave, Ste 402, 
Wyomissing, PA 
Languages Spoken:
English

. Dr. Gabriely is rated as an Advanced provider by MediFind in the treatment of Panhypopituitarism. His top areas of expertise are Low Blood Sugar, Hyperparathyroidism, Thyroid Cancer, and Anaplastic Thyroid Cancer.

Jeffrey S. Freeman
Advanced in Panhypopituitarism
Endocrinology | Internal Medicine
Advanced in Panhypopituitarism
Endocrinology | Internal Medicine

Jeffrey S. Freeman DO

4190 City Ave, Ste 324, 
Philadelphia, PA 
Languages Spoken:
English
Offers Telehealth

. Dr. Freeman is rated as an Advanced provider by MediFind in the treatment of Panhypopituitarism. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, and Graves Disease.

 
 
 
 
Learn about our expert tiers
Learn More
Rita A. Kubicky
Advanced in Panhypopituitarism
Pediatric Endocrinology
Advanced in Panhypopituitarism
Pediatric Endocrinology

St. Christopher's Pediatric Associates Endocrinology - E. Erie Avenue

160 E Erie Ave, 
Philadelphia, PA 
Languages Spoken:
English

. Dr. Kubicky is rated as an Advanced provider by MediFind in the treatment of Panhypopituitarism. Her top areas of expertise are Acanthosis Nigricans, Type A Insulin Resistance Syndrome, Pseudohypoparathyroidism, and Albright's Hereditary Osteodystrophy.

What are the latest Panhypopituitarism Clinical Trials?
A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients With Acquired Hypothalamic Obesity

Summary: This is a sub-study of Study RM-493-040 (NCT05774756). The goal of this sub-study is to learn how well Setmelanotide works to improve weight reduction, hunger, and quality of life in patients 4 years of age and older with congenital Hypothalamic Obesity (cHO). To determine how well setmelanotide works and how safe it is, patients with cHO will take a daily injection of either setmelanotide or plac...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Clinical and Genetic Investigation of Pituitary and Hypothalamic Tumors and Related Disorders

Summary: There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors (eg craniopharyngioma) are included among the most common central nervous system tumors in childhood. The gene(s) involved in the pathogenesis of these tumors are largely not known; their possible association with other developmental defects or inheritance pattern(s) has not been investigated. The present...

Who are the sources who wrote this article ?

Published Date: May 07, 2025
Published By: National Institutes of Health